Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Beatriz Godoi Cavalheiro has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prognostic significance of minimal extrathyroidal extension in differentiated thyroid carcinoma: a retrospective cohort study

    by Beatriz G. Cavalheiro, Vergilius José Furtado de Araújo Filho, Leandro Luongo Matos, Ana Kober Leite, Claudio Roberto Cernea, Luiz Paulo Kowalski

  • Open Access

    Evaluation of epithelial-to-mesenchymal transition and Ki-67 index in aggressive papillary thyroid cancer

    by Luana Perrone Camilo, Paula Vianna, Venancio Avancini Ferreira Alves, Beatriz Godoi Cavalheiro, Carlos Augusto Rossetti, Luiz Paulo Kowalski, Leandro Luongo Matos, Ana Kober Nogueira Leite


  • Open Access

    Thyroid surgery volume – A statement issued by the Brazilian Head and Neck Surgery Society (SBCCP)

    by Fatima Cristina Mendes de Matos, José Guilherme Vartanian, José Carlos Barauna, Ary Serrano Santos, Achilles Alves de Levy Machado, Paola Andrea Galbiatti Pedruzzi, Murilo Catafesta das Neves, Flavio Carneiro Hojaij, Marianne Yumi Nakai, Aline de Oliveira Ribeiro Viana, et al.

    DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement [...] DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement


  • Open Access

    Incidental Node Metastasis as an Independent Factor of Worse Disease-Free Survival in Patients with Papillary Thyroid Carcinoma

    by Renan Aguera Pinheiro, Ana Kober Leite, Beatriz Godoi Cavalheiro, Evandro Sobroza de Mello, Luiz Paulo Kowalski, Leandro Luongo Matos

    Introduction: Papillary thyroid carcinoma (PTC) have high node metastasis rates. Occasionally after thyroidectomy, the pathological report reveals node metastasis unintentionally resected. The present study aimed to evaluate the prognosis of these patients. Methods: A retrospective cohort of patients submitted to thyroidectomy with or without central compartment neck dissection (CCND) due to PTC with a minimum follow-up of five years. Results: A total of 698 patients were included: 320 Nx, 264 pN0-incidental, 37 pN1a-incidental, 32 pN0-CCND and 45 pN1a-CCND. Patients with node metastasis were younger, had larger tumors, higher rates of microscopic extra-thyroidal extension, and angiolymphatic invasion and most received radioiodine therapy. Treatment failure was higher in patients pN1a-incidental and pN1a-CCND (32% and 16%, respectively; p < 0.001—Chi-square test). Disease-free survival (DFS) was lower in patients pN1a-incidental compared to patients Nx and pN0-incidental (p < 0.001 vs. Nx and pN0-incidental and p = 0.005 vs. pN0-CCND) but similar when compared to patients pN1a-CCND (p = 0.091)—Log-Rank test. Multivariate analysis demonstrated as independent risk factors: pT4a (HR = 5.524; 95%CI: 1.380–22.113; p = 0.016), pN1a-incidental (HR = 3.691; 95%CI: 1.556–8.755; p = 0.003), microscopic extra-thyroidal extension (HR = 2.560; 95%CI: 1.303–5.030; p = 0.006) and angiolymphatic invasion (HR = 2.240; 95%CI: 1.077–4.510; p = 0.030). Conclusion: Patients that were pN1a-incidental were independently associated with lower DFS.


  • Open Access

    Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review

    by Beatriz G. Cavalheiro, Jatin P. Shah, Gregory W. Randolph, Jesus E. Medina, Ralph P. Tufano, Mark Zafereo, Dana M. Hartl, Iain J. Nixon, Orlando Guntinas-Lichius, Vincent Vander Poorten, et al.

    Surgery has been historically the preferred primary treatment for patients with well-differentiated thyroid carcinoma and for selected locoregional recurrences. Adjuvant therapy with radioactive iodine is typically recommended for patients with an intermediate to high risk of recurrence. Despite these treatments, locally advanced disease and locoregional relapses are not infrequent. These patients have a prolonged overall survival that may result in long periods of active disease and the possibility of requiring subsequent treatments. Recently, many new options have emerged as salvage therapies. This review offers a comprehensive discussion and considerations regarding surgery, active surveillance, radioactive iodine therapy, ultrasonography-guided percutaneous ablation, external beam radiotherapy, and systemic therapy for well-differentiated thyroid cancer based on relevant publications and current reference guidelines. We feel that the surgical member of the thyroid cancer management team is empowered by being aware and facile with all management options.


  • Open Access

    Profile of MicroRNAs Associated with Death Due to Disease Progression in Metastatic Papillary Thyroid Carcinoma Patients

    by Ana Kober Leite, Kelly Cristina Saito, Thérèse Rachell Theodoro, Fátima Solange Pasini, Luana Perrone Camilo, Carlos Augusto Rossetti, Beatriz Godoi Cavalheiro, Venâncio Avancini Ferreira Alves, Luiz Paulo Kowalski, Maria Aparecida Silva Pinhal, et al.

    Papillary thyroid carcinoma (PTC) is the most common neoplasm of the endocrine system and has an excellent long-term prognosis, with low rates of distant metastatic disease. Although infrequent, there are cases of deaths directly related to PTC, especially in patients with metastatic disease, and the factors that could be associated with this unfavorable outcome remain a major challenge in clinical practice. Recently, research into genetic factors associated with PTC has gained ground, especially mutations in the TERT promoter and BRAF gene. However, the role of microRNAs remains poorly studied, especially in those patients who have an unfavorable outcome at follow-up. This paper aims to evaluate molecular markers related to the different pathological processes of PTC, as well as the histological characteristics of the neoplasm, and to compare this profile with prognosis and death from the disease using an analysis of patients treated for metastatic disease in a single tertiary cancer center. Evaluation of microRNA expression in paraffin-embedded tumor specimens was carried out by quantitative PCR using the TaqMan® Low Density Array (TLDA) system. Metastatic patients who died from progression of PTC had higher expressions of miR-101-3p, miR-17-5p, and miR-191-5p when compared to patients with stable metastatic disease. These findings are of great importance but should be considered as preliminary because of the small sample.


  • Open Access

    Impact of the COVID-19 Pandemic on Brazilian Head and Neck Surgery Centers

    by Gustavo Fernandes de Alvarenga, Ana Kober Nogueira Leite, Carlos Neutzling Lehn, Rogério Aparecido Dedivitis, Marianne Yumi Nakai, Beatriz Godoi Cavalheiro, Gilberto Vaz Teixeira, Rafael De Cicco, Luiz Paulo Kowalski, Leandro Luongo de Matos


  • Risk factors associated with disease-specific mortality in papillary thyroid cancer patients with distant metastases

    by Kamilla Schmitz Nunes, Leandro Luongo Matos, Beatriz Godoi Cavalheiro, Felipe Ferraz Magnabosco, Marcos Roberto Tavares, Marco Aurélio Kulcsar, Ana Oliveira Hoff, Luiz Paulo Kowalski, Ana Kober Leite

    Purpose Papillary thyroid carcinoma (PTC) is among the most curable cancer types. Even though uncommon, some patients present distant metastatic disease at diagnosis or during the follow-up and most of them have long-term survival. However, there continues to be controversies regarding what clinicopathological features are associated with mortality in these patients. This paper evaluates the factors related to poor disease-specific survival (DSS) in patients with metastatic PTC. Methods A retrospective cohort study included PTC patients with distant metastasis from a tertiary public oncological center. Clinicopathological features, treatment modalities, and outcome were reviewed. Results Between 1986 and 2014, 108 patients were diagnosed with metastatic PTC. In the multivariate analysis male sex (HR = 2.65; 95%CI: 1.08–6.53; P = 0.033), radioiodine refractory disease (HR = 9.50; 95%CI: 1.23–73.38; P = 0.031) and metastasis at multiple sites (HR = 5.91; 95%CI: 1.80–19.32; P = 0.003) were independent risk factors for death in patients with metastatic PTC. Conclusion Male patients with metastatic PTC, with radioiodine refractory disease and metastasis at multiple sites have a high risk of death.


  • Survival in differentiated thyroid carcinoma: Comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system

    by Beatriz Godoi Cavalheiro, Leandro Luongo de Matos, Ana Kober Nogueira Leite, Marco Aurelio Vamondes Kulcsar, Claudio Roberto Cernea, Luiz Paulo Kowalski

    Background: The AJCC/UICC TNM staging system evaluates the risk of death from cancer. Its 8th edition aimed to increase its accuracy. In turn, the American Thyroid Association proposed an initial risk stratification system (IRSS) focusing on the risk of recurrence in differentiated thyroid carcinoma. The present study intended to analyze their prediction abilities.Methods: Six hundred and eighty‐five consecutive surgical patients (mean follow‐up 71.6 months) were staged. Correlations with disease‐free survival (DFS) and overall survival (OS) were carried out.Results: IRSS was discriminative for DFS but not for OS. Applying TNM 8th, 36.9% of the cohort was downstaged. Their DFS was shorter, compared with other patients in the same stage, but with no impact on OS. However, all those who died of the disease had been downstaged.Conclusions: IRSS was more effective to predict DFS, but not OS. TNM 8th was more appropriate for OS analysis than TNM 7th and IRSS.


  • Open Access

    Surgical treatment for thyroid carcinoma: retrospective study with 811 patients in a Brazilian tertiary hospital

    by Beatriz G. Cavalheiro, Leandro L. Matos, Ana Kober N. Leite, Marco Aurélio V. Kulcsar, Claudio R. Cernea, Lenine G. Brandão

    Key words: Thyroid diseases; thyroid neoplasms; epidemiology; prognosis